In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.
Bibliographical notePublisher Copyright:
© The Author 2016.
- Antimicrobial resistance
- Meningococcal disease
- Neisseria meningitidis